Vandromme J - Search Results

1

Decrease of bone mineral density during estrogen substitution therapy.

Rozenberg S, Gevers R, Peretz A, Vandromme J, Robyn C, Ham H. Rozenberg S, et al. Among authors: vandromme j. Maturitas. 1993 Nov;17(3):205-10. doi: 10.1016/0378-5122(93)90048-m. Maturitas. 1993. PMID: 8133795

2

Propensity of gynaecologists towards osteoporosis management and treatment.

Rozenberg S, Murillo D, Gevers R, Vandromme J. Rozenberg S, et al. Among authors: vandromme j. Maturitas. 2006 Mar 20;53(4):483-8. doi: 10.1016/j.maturitas.2005.08.004. Epub 2005 Sep 22. Maturitas. 2006. PMID: 16182476

3

Attitudes to the prescription of menopause hormone therapy for vasomotor symptoms and osteoporosis for patients of different ages: A survey of gynecologists in Belgium.

Rozenberg S, Vandromme J. Rozenberg S, et al. Among authors: vandromme j. Maturitas. 2019 Oct;128:60-63. doi: 10.1016/j.maturitas.2019.07.024. Epub 2019 Aug 5. Maturitas. 2019. PMID: 31561825

4

Time related bias in longitudinal studies using dual photon absorptiometry.

Rozenberg S, Vandromme J, Peretz A, Praet JP, Robyn C, Ham H. Rozenberg S, et al. Among authors: vandromme j. J Endocrinol Invest. 1992 Dec;15(11):835-7. doi: 10.1007/BF03348815. J Endocrinol Invest. 1992. PMID: 1291595

5

Overview of the clinical usefulness of bone mineral measurements in the prevention of postmenopausal osteoporosis.

Rozenberg S, Vandromme J, Kroll M, Praet JP, Peretz A, Ham H. Rozenberg S, et al. Among authors: vandromme j. Int J Fertil Menopausal Stud. 1995 Jan-Feb;40(1):12-24. Int J Fertil Menopausal Stud. 1995. PMID: 7749430 Review.

6

Clinical significance of heterogeneity of vertebral mineral density.

Rozenberg S, Vandromme J, Aguillera A, Peretz A, Ham H. Rozenberg S, et al. Among authors: vandromme j. Maturitas. 1995 Feb;21(2):147-51. doi: 10.1016/0378-5122(94)00879-c. Maturitas. 1995. PMID: 7752952

7

Bone mineral density measured by dual photon and dual energy X-ray absorptiometry: a problem of accuracy.

Rozenberg S, Peretz A, Praet JP, Vandromme J, Ham H. Rozenberg S, et al. Among authors: vandromme j. Nucl Med Commun. 1993 Mar;14(3):189-91. doi: 10.1097/00006231-199303000-00007. Nucl Med Commun. 1993. PMID: 8455909

8

Effect of bone density evaluation on hormone replacement therapy prescription.

Rozenberg S, Kroll M, Vandromme J, Paesmans M, Ham H. Rozenberg S, et al. Among authors: vandromme j. Maturitas. 1996 May;24(1-2):57-61. doi: 10.1016/0378-5122(95)01002-5. Maturitas. 1996. PMID: 8794435

9

Factors influencing the prescription of hormone replacement therapy.

Rozenberg S, Kroll M, Vandromme J, Paesmans M, Lefever A, Ham H. Rozenberg S, et al. Among authors: vandromme j. Obstet Gynecol. 1997 Sep;90(3):387-91. doi: 10.1016/s0029-7844(97)00268-8. Obstet Gynecol. 1997. PMID: 9277649

10

Prescription attitudes among gynecologists towards two particular risk factors of osteoporosis: the patient's age and her bone mineral density.

Rozenberg S, Lefever A, Kroll M, Vandromme J, Paesmans M, Ham H. Rozenberg S, et al. Among authors: vandromme j. Maturitas. 1999 May 31;32(1):19-24. doi: 10.1016/s0378-5122(99)00002-x. Maturitas. 1999. PMID: 10423712

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters